| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 05/25/2005 | EP1532259A1 Non-human herpesviruses as vectors |
| 05/25/2005 | EP1532254A2 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 05/25/2005 | EP1532167A2 Molecular antigen arrays using a virus like particle derived from the ap205 coat protein |
| 05/25/2005 | EP1532161A2 Vectors for expression of hml-2 polypeptides |
| 05/25/2005 | EP1531692A1 Virulent phages to control listeria monocytogenes in foodstuffs and in food processing plants |
| 05/25/2005 | EP0688227B1 Production of human papillomavirus capsid protein and virus-like particles |
| 05/25/2005 | CN1620500A Corona-virus-like particles comprising functionally deleted genomes |
| 05/25/2005 | CN1620310A Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| 05/25/2005 | CN1618967A Configuration of high effect expression serum albumin yeast strain and fermentation purification technology |
| 05/25/2005 | CN1618956A Virus strain for preventing poultry influenza and its animal infection model |
| 05/25/2005 | CN1618464A Enhanced immunogen for inactivated vaccine for infection with Japanese ence phalitis viruses and process for producing the same |
| 05/25/2005 | CN1203183C Retroviral vectors comprising functional splice donor site and a functional splice acceptor site |
| 05/24/2005 | US6897359 Carnation antisense deoxyhypusine synthase molecule and method of inhibiting deoxyhypusine synthase expression in plants |
| 05/24/2005 | US6897063 Accessory functions for use in recombinant AAV virion production |
| 05/24/2005 | US6897057 Cell-specific and/or tumor-specific promoter retargeting of herpes γ 34.5 gene expression |
| 05/24/2005 | US6896882 Breaking peptidoglycans in cell wall; destroying genomes |
| 05/19/2005 | WO2005045014A1 Method of producing baculovirus |
| 05/19/2005 | WO2004104190A3 Methods and compositions for the production of adenoviral vectors |
| 05/19/2005 | WO2004060912A3 Chimeric capsid proteins and expression vectors for monocistronic expression of multiple genes |
| 05/19/2005 | WO2004022762A9 Orthopoxvirus vectors, genes and products thereof |
| 05/19/2005 | WO2003092592A3 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 |
| 05/19/2005 | US20050107326 GENETIC ENGINEERED nucleic acid, VECTOR CODING ANTISENSE AGENTS; FOR USE IN KILLING PREFERENTIAL TARGET CELLS OR MICRORGANISMS; biodrugs as antitumor agent, bactericides, anticarcinogenic agent; target on antibiotic resistant bacteria, drug-resistant cancer cells |
| 05/19/2005 | US20050106733 Double-stranded cyclic dna capable of proliferating as a bacterial e coli chromosome |
| 05/19/2005 | US20050106663 viral vector containing a polynucleotide sequence contains two different affinity tag sequences, one of the two affinity tag sequences encodes streptavidin-binding peptide and other encodes calmodulin binding peptide |
| 05/19/2005 | US20050106581 Phosphodiesterase polypeptides for use in identifying modulators for prevention and treatment of inflammatory disease |
| 05/19/2005 | DE19905501B4 Verfahren zur Herstellung eines rekombinanten Adeno-assoziierten Virus, geeignete Mittel hierzu sowie Verwendung zur Herstellung eines Arzneimittels A method of producing a recombinant adeno-associated virus, as well as suitable means to this end use for the preparation of a medicament |
| 05/19/2005 | CA2545177A1 Method of producing baculovirus |
| 05/18/2005 | EP0844888B1 Adenovirus vectors comprising a prostate specific antigen (psa) response element |
| 05/18/2005 | CN1617924A Method for large scale production of virus antigen |
| 05/18/2005 | CN1617923A Method of large scale production of hepatitis a virus |
| 05/18/2005 | CN1617882A Method of isolation and purification of trypsin from pronase protease and use thereof |
| 05/18/2005 | CN1617741A Method of production of purified hepatitis a virus particles and vaccine preparation |
| 05/18/2005 | CN1616670A 感染性克隆 Infectious clone |
| 05/18/2005 | CN1616665A Targeted liposome gene delivery |
| 05/18/2005 | CN1616654A Inactivating and purifying method for SARS virus and method for preparing said inactivated virus vaccine and said vaccine |
| 05/18/2005 | CN1616107A Gene engineering recombined vaccine of carcinoma of cervix uterus |
| 05/18/2005 | CN1616096A Method for cultivating attenuated strain pilio inactivated vaccine |
| 05/18/2005 | CN1616095A After treatment method for attenuated strain polio inactivated vaccine |
| 05/18/2005 | CN1202251C Infectious bursal disease virus (IBDV) polyprotein gene (VP2/VP4/VP3) eukaryon expressing plasmid and DNA vaccine |
| 05/18/2005 | CN1202126C Recombinant Newcastle disease virus capable of being used as embryo vaccine |
| 05/17/2005 | US6894157 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 05/17/2005 | US6893869 For treatment of cancer/tumors/fungal/viral infections; tumor associated antigens; genetic engineering |
| 05/17/2005 | US6893865 Methods, compositions, and cells for encapsidating recombinant vectors in AAV particles |
| 05/17/2005 | US6893840 Cytomegalovirus Intron A fragments |
| 05/17/2005 | US6893643 Comprises exogenous nucleotide sequences which encode exogenous amino acid sequences; infection of host cell with recombinant Yellow Fever Virus provides for expression of exogenous nucleic acid and production of antigen |
| 05/17/2005 | US6893634 Without inflammatory or other immune response side effects; injection or implantation in tissue containing cancer growth; porous cellulose sulphate and polydimethyldiallylammonium membrane; breast and/or pancreatic tumors |
| 05/17/2005 | CA2132374C Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease |
| 05/12/2005 | WO2005042733A1 Hbv variants detection and application |
| 05/12/2005 | WO2005042728A2 Immortalized avian cell lines for virus production |
| 05/12/2005 | WO2005042714A2 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
| 05/12/2005 | WO2005042014A1 West nile virus vaccine |
| 05/12/2005 | WO2005026192A3 Hpv cd8+ t-cell epitopes |
| 05/12/2005 | WO2005005596A3 Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof |
| 05/12/2005 | WO2004110370A3 Etiologic agnet for sow infertility syndrome |
| 05/12/2005 | US20050100952 Transgenic mammalian cells for use as bioreactors in expression of heterologous gene sequences |
| 05/12/2005 | US20050100890 Viron for use as gene transfer construct; gene therapy and tissue targeted therapy; drug delivery |
| 05/12/2005 | US20050100557 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 05/12/2005 | US20050100556 DNA viral vaccine fusion for use in prevention of viral infections and as a drug delivery tool |
| 05/12/2005 | US20050100552 Baculovirus vector, expressed in insect cells; induce apoptosis; introduced into tumor cell by viral vector, liposome, a conjugate, injection, electroporation, particle bombardment |
| 05/12/2005 | CA2543538A1 Hbv variants detection and application |
| 05/12/2005 | CA2534236A1 Lipoparticles comprising proteins, methods of making, and using the same |
| 05/11/2005 | EP1529113A1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 05/11/2005 | EP1529103A1 Method for inducing complete hepatitis c virus (hcv) replication in vitro |
| 05/11/2005 | EP1124575B1 Method for the production of an antiviral agent |
| 05/11/2005 | CN1614011A Technology for closed double-circulating column chromatographing purifying inactivated virus vaccine |
| 05/11/2005 | CN1201013C Adenovirus vectors and method for reducing homologous recombination phnomena |
| 05/10/2005 | US6891085 Nucleotidesequences coding polypeptide associated with the generation of disease resistant plants |
| 05/10/2005 | CA2330935C A mutant human hepatitis b viral strain and uses thereof |
| 05/10/2005 | CA2067330C Herpes simplex virus type 1 mutant |
| 05/10/2005 | CA1341482C Process for preparing fragments of aids-associated retroviruses |
| 05/06/2005 | WO2005040390A1 A recombinant vaccine using yellow fever virus as vector |
| 05/06/2005 | WO2005040365A1 Immunogenic composition and method of developing a vaccine based on portions of the hiv matrix protein |
| 05/06/2005 | WO2005040353A2 Immunogenic compostion and method of developing a vaccine based on psoralen inactivated hiv |
| 05/06/2005 | WO2005040352A2 Immunogenic composition and method of developing a vaccine based on factor h binding sites |
| 05/06/2005 | WO2005040349A2 Immunogenic composition and method of developing a vaccine based on cyclophilin a binding site |
| 05/06/2005 | WO2005040333A2 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism |
| 05/06/2005 | WO2005040188A1 Hepatocellular carcinoma specific promoter and uses thereof |
| 05/06/2005 | WO2005039501A2 Immunogenic composition and method of developing a vaccine based on fusion protein |
| 05/06/2005 | CA2543200A1 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism |
| 05/06/2005 | CA2541511A1 Immunogenic composition and method of developing a vaccine based on portions of the hiv matrix protein |
| 05/06/2005 | CA2541506A1 Immunogenic compostion and method of developing a vaccine based on psoralen inactivated hiv |
| 05/06/2005 | CA2541501A1 Immunogenic composition and method of developing a vaccine based on factor h binding sites |
| 05/06/2005 | CA2541497A1 Immunogenic composition and method of developing a vaccine based on cyclophilin a binding site |
| 05/06/2005 | CA2541492A1 Immunogenic composition and method of developing a vaccine based on fusion protein |
| 05/06/2005 | CA2540023A1 Hepatocellular carcinoma specific promoter and uses thereof |
| 05/05/2005 | US20050095713 Vectors for gene mutagenesis and gene discovery |
| 05/05/2005 | US20050095705 Cell comprising replication-competent adenovirus vector for use as tool in generating gene therapeutic vectors; tissue directed therapy |
| 05/05/2005 | US20050095692 Generation and recovering of preferential viral particles; obtain cells, infect with virus, extract virus from cells using detergent, recover virus |
| 05/05/2005 | US20050095231 Transduction; gene therapy; replacing capsid with chimeric molecule containing heterologous trimerization motif and stabilized scFv ligand; host cells |
| 05/04/2005 | EP1528101A1 Immortalized avian cell lines for virus production |
| 05/04/2005 | EP1527171A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 05/04/2005 | CN1612942A Viral capsid assembly intermediates |
| 05/04/2005 | CN1612940A Highly-sensitive genomic assays employing chimeric bacteriophage standards |
| 05/03/2005 | US6887977 Methods and materials relating to CD8-tropic HIV-1 |
| 05/03/2005 | US6887707 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA |
| 05/03/2005 | US6887479 Attenuated recombinant rabies virus mutants and live vaccines thereof |
| 05/03/2005 | US6887478 Genetic engineered caspid genes and proteins which which mimic epitopes on human and animal DNA viruses, used for prophylaxis of viral diseases; immunology |
| 05/03/2005 | US6887464 Plurality of genetically engineered nucleocapsid protein monomers derived from duck hepatitis B virus; immune response, gene therapy |
| 05/03/2005 | US6887463 Recombinant viral vector encoding a human very low density lipoprotein (VLDL) receptor, operatively linked to regulatory sequences directing expression in a hepatocyte; familial hypercholesterolemia or hyperlipidemia |
| 05/03/2005 | CA2179017C Peracetic acid sterilization |